ADaptive ASsessment of TReatments for influenzA: A Phase 2 Platform Trial of Antiviral Pharmacodynamics in Early Symptomatic Influenza

Conditions:   Influenza;   Influenza, Human Interventions:   Drug: Drug: Oseltamivir;   Drug: Drug: Favipiravir;   Drug: Drug: Zanamivir;   Drug: Drug: Baloxavir;   Drug: Drug: Molnupiravir;   Drug: Drug: Peramivir;   Drug: Drug: Laninamivir Sponsor:   University of Oxford Not yet recruiting

Source: ClinicalTrials.gov - December 13, 2022 Category: Research Source Type: clinical trials